Core Insights - Strata Critical Medical, Inc. reported a strong Q4 2025 with organic growth of 35%, exceeding expectations and leading to a full-year performance that surpassed guidance on all fronts [1][24] - The company is raising its revenue and adjusted EBITDA guidance for 2026 due to strong volumes and new customer acquisitions [1][29] Financial Performance - Full-year 2025 revenue reached $197.1 million and adjusted EBITDA was $14.1 million, both exceeding the high end of guidance [24] - Q4 2025 revenue was $66.8 million, driven by logistics growth of 35.3% to $49.2 million compared to $36.4 million in the prior year [24][27] - Clinical revenue in Q4 2025 was $17.6 million, significantly up from $2.8 million in Q3 2025, reflecting the impact of the Keystone acquisition [24][25] Growth Strategy - Continued acquisitions of smaller businesses are a key part of the company's strategy to accelerate growth and expand geographically [5][15] - The company expects to maintain an average annualized adjusted EBITDA growth rate of at least 30% over the coming years, driven by successful execution of its M&A strategy [15][16] Regulatory Environment - Recent regulatory changes are seen as beneficial for Strata Critical Medical, particularly in incentivizing the pursuit of medically complex organs [8][10] - The company is well-positioned with a customer base that is over-indexed to larger, more sophisticated transplant centers, which are favored under new regulations [10][11] Operational Highlights - The company ended the year with a fleet of approximately 30 dedicated or owned aircraft and plans to add two new owned aircraft to support new geographies in 2026 [12][13] - Logistics gross profit increased by 39.5% to $10.6 million in Q4 2025, driven by strong revenue growth and improved gross margins [27] Future Outlook - The company raised its 2026 revenue guidance range to $260–$275 million from $255–$270 million previously, and adjusted EBITDA guidance to $29–$33 million from $28–$32 million [29] - Despite a modest sequential revenue decline expected in Q1 2026, the company anticipates a sequential improvement in revenue and margin in the second quarter and the latter half of the year [31]

AI chip startup Rebellions has appointed JPMorgan Chase & Co. as global lead underwriter for its initial public offering in Seoul, setting the stage for one of South Korea’s most closely watched technology debuts. https://t.co/qFG9l2dbsQ ...

Core Points - INVL Technology received notification from the Bank of Lithuania allowing changes to its Articles of Association [1] - The new wording of the Articles of Association was registered on 17 February 2026 [1] - The approval for the new Articles of Association occurred during the General Shareholders Meeting on 5 February 2026 [1]

RT Mr hunter (@TrueGemHunter)Today is the start of the historical market shift.Market is going to crackI am expecting 👇Oil → $120 to $150Gold → $6,000 to $7,000Silver → $125Nasdaq → 20 to 35% dropBitcoin → below $40KETH → below $1000SOL → below $36The world is not ready for this. https://t.co/xy8myfJf9z ...

🚨JUST IN: BITCOIN TO HIT $11 MILLION PER COIN@IIICapital, VP of Bitcoin Strategy @Strive, has shared a base case of $BTC reaching $11M per coin by 2036.Burnett believes that gains in productivity from AI technology will create deflationary pressure across goods and services, which in turn...... will force central banks to expand monetary supplies and in a big way indeed.With that said, Burnett's forecast is certainly ambitious, requiring a 176x increase in Bitcoin's market cap from current levels, as highli ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Endeavor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Endeavor between November 6, 2024 and January 23, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Fa ...

侨银转债：提议下修 百润转债：下修到底 凌钢转债：到期前最后交易日：2026年4月7日 海菲曼：北交所新股【上市】 | 转债代码 | 转债名称 | 现价 | 赎回价 | 最后交易日 | 最后转股日 | 转股价值 | 剩余规模 | 转债占正股 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (税前) | | | | (亿元) | 流通市值比 | | 110067 | 华安转债 | 108.190 | 107.000 | 2026-03-06 | 2026-03-11 | 107.61 | 17.816 | 5.99% | | 128101 | 联创转债 | 111.070 | 110.000 | 2026-03-11 | 2026-03-16 | 100.36 | 2.944 | 2.49% | | 123108 | 乐普转2 | 107.615 | 107.800 | 2026-03-24 | 2026-03-27 | 61.06 | 16.374 | 6.10% | | 113574 | 华体转债 | 116.799 | 1 ...

今年回老家过年，和亲戚邻居聊天，发现县城和乡下赌博现象比较普遍，参与的主力多为80 后和90后，这帮人赌起来，往往金额比较大，我听到的就有好几个同村的青年去年欠下了大 额赌债，从20多万到100多万不等，基本上都找自己的亲戚朋友借了一遍，甚至还有借网贷 来还赌债的。他们都是在县城务工或者做小生意的，几十万的金额，对他们不是一个小的数 字，目前经济不景气，这些人收入都不太稳定，不太理解他们为什么还要参与这么大额的赌 博。 rain 都是些无知的人。 如果你有个合法，收入免税，抽成低，玩法花样多，有简单的比大小，也有比轮盘复杂的， 免息融资，保证不出老千，这样的场子，你不想去玩吗？？？还要去玩那些黑场子吗？ 想想咱大A，这么好的场子，合法，赢了钱免税。 因为场子大，成本低，场子抽成也比黑场子低得多。 如果嫌玩的不大，还可以免利息融资做期货。 如果说不会玩，就赌个一定时间的涨跌，跟玩大小点不是一样的概率吗？比百家乐都容易。 即使有个千万拿上台面，大庄家也看不上你这三瓜两枣，犯不上对你出老千。肯定比黑场子 公平。多好的场子！ 如果你钱多，不想玩那么大风险的，还可以做个回购给别人融资，合法收点利息。 交易所们呀，都开了 ...

Core Insights - Kontoor Brands (NYSE:KNG) reported a strong performance for Q4 2025, achieving an adjusted EPS of $1.73, surpassing the consensus estimate of $1.67 by 4.85% [1] Financial Performance - The company delivered a clean double beat in its earnings report for fiscal 2026, indicating robust financial health and operational efficiency [1]

Core Viewpoint - Palantir's stock experienced a nearly 6% increase following a successful close, but saw a 2% decline in pre-market trading due to insider selling activity, particularly by co-founder Peter Thiel, who plans to sell 2 million shares valued at approximately $280 million [1][2]. Group 1: Stock Performance and Analyst Ratings - Rosenblatt Securities upgraded Palantir's stock price target from $150 to $200, maintaining a 'Buy' rating amid rising geopolitical tensions and increased demand for defense technologies [2]. - The revised price target reflects a 1.2x price-to-earnings growth (PEG) ratio based on projected 2027 earnings per share of 88x, up from a previous assumption of 0.9x [4]. - The average price forecast for Palantir over the next twelve months is $191.76, indicating an upside potential of approximately 32% based on twenty analyst notes collected by TipRanks [4]. Group 2: Market Context and Future Projections - Analyst John McPeake suggests that escalating conflicts, particularly in the Middle East, may highlight the advantages of Palantir's integrated platforms compared to standalone large language models [3]. - The firm anticipates that global instability will lead to further consolidation of government contracts, similar to a previous agreement with the U.S. Army that combined 75 contracts under a single Palantir deal [3]. - Rosenblatt's forecasts for Palantir's 2027 performance remain above consensus, projecting a 38% rally, with only Citi and Morgan Stanley being more optimistic about the company [5].